Horizon Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.95M Buy
13,242
+11,608
+710% +$6.09M 0.11% 149
2025
Q1
$1.04M Buy
1,634
+59
+4% +$37.4K 0.03% 271
2024
Q4
$1.12M Buy
1,575
+23
+1% +$16.4K 0.03% 256
2024
Q3
$1.63M Sell
1,552
-99
-6% -$104K 0.04% 208
2024
Q2
$1.74M Buy
1,651
+7
+0.4% +$7.36K 0.05% 184
2024
Q1
$1.58M Buy
1,644
+36
+2% +$34.7K 0.04% 198
2023
Q4
$1.41M Buy
1,608
+800
+99% +$703K 0.04% 190
2023
Q3
$665K Buy
808
+23
+3% +$18.9K 0.02% 232
2023
Q2
$564K Sell
785
-54
-6% -$38.8K 0.02% 267
2023
Q1
$689K Sell
839
-577
-41% -$474K 0.02% 230
2022
Q4
$1.02M Sell
1,416
-1,634
-54% -$1.18M 0.03% 216
2022
Q3
$2.1M Buy
3,050
+897
+42% +$618K 0.06% 108
2022
Q2
$1.27M Sell
2,153
-2,255
-51% -$1.33M 0.04% 156
2022
Q1
$3.08M Buy
4,408
+793
+22% +$554K 0.09% 108
2021
Q4
$2.28M Buy
3,615
+1,283
+55% +$810K 0.07% 131
2021
Q3
$1.41M Buy
2,332
+620
+36% +$375K 0.04% 175
2021
Q2
$956K Sell
1,712
-570
-25% -$318K 0.03% 220
2021
Q1
$1.08M Buy
+2,282
New +$1.08M 0.04% 196
2020
Q4
Sell
-2,613
Closed -$1.46M 330
2020
Q3
$1.46M Sell
2,613
-2,735
-51% -$1.53M 0.05% 153
2020
Q2
$3.34M Buy
5,348
+4,290
+405% +$2.68M 0.08% 112
2020
Q1
$517K Buy
1,058
+114
+12% +$55.7K 0.03% 178
2019
Q4
$354K Buy
+944
New +$354K 0.02% 363
2019
Q3
Sell
-705
Closed -$221K 518
2019
Q2
$221K Buy
705
+203
+40% +$63.6K 0.01% 509
2019
Q1
$206K Buy
+502
New +$206K 0.01% 401